InvestorsHub Logo
Followers 6
Posts 201
Boards Moderated 0
Alias Born 10/11/2016

Re: None

Monday, 06/01/2020 9:19:14 AM

Monday, June 01, 2020 9:19:14 AM

Post# of 233220
Anyone who has been paying attention for the past year or so, has to realize that NP is using PR's as a strategic tool to maintain the pps, and keep investors informed. Whether we agree or disagree doesn't change what he is doing. With a share price that moved from .30 to 3.00 I see no reason to be critical. OTOH, if he PR's puff pieces or insignificant accomplishments, the market reacts and the price goes down. As an investor or trader, we need to be aware of his strategy and use it to our advantage.

Looks like CYDY will be up today. If the PR is a blow-out, it will continue to rise tomorrow. If it is a blow-up, it will go down tomorrow. He will definitely spin it to be good news. How the market takes it is another story. Perhaps he will have an update on priority BLA status for Leronlimab in HIV. That is not only newsworthy, but buy worthy. Or he may have some comments on adding more patients to the COVID trials.

CYDY is definitely a trading instrument, but you can easily get caught predicting his PR's. If you believe in Leronlimab for the long-term, then you and I will probably make better decisions.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News